Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 9/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 9/20 | 0.48 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | NRP1 | O14786 | 1/20 | 0.44 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.42 |
| ▸ | CALCR | P30988 | 2/20 | 0.42 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21043608 | 1.00 | OPRM1 (0.48) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL1247799 | 1.00 | OPRM1 (0.48) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL7263725 | 1.00 | OPRM1 (0.48) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL12899263 | 1.00 | OPRM1 (0.48) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL1247795 | 1.00 | OPRM1 (0.48) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL12261069 | 0.97 | GRB2 (0.50) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL13084631 | 0.97 | GRB2 (0.50) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL14227389 | 0.97 | GRB2 (0.50) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL12899266 | 0.97 | GRB2 (0.50) | OPRM1OPRK1GRB2F2NRP1 | |
| SCHEMBL12237919 | 0.97 | GRB2 (0.50) | OPRM1OPRK1GRB2F2NRP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4086 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069654-A1 | NANOAGONIST, AND PREPARATION METHOD AND USE THEREOF | UNIV CHONGQING (CN) | 2026-03-12 | — | — | US | claimed |
| US-20260021158-A1 | GRANULAR COMPOSITIONS COMPRISING A PEPTIDE AND USES THEREOF | Tarsier Pharma Ltd (IL) | 2026-01-22 | — | — | US | claimed |
| US-20250375529-A1 | PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE FOR TREATING OCULAR INFLAMMATION | Tarsier Pharma Ltd (IL) | 2025-12-11 | — | — | US | claimed |
| US-20250186535-A1 | OPHTALMIC COMPOSITIONS AND METHODS OF USING SAME | TARSIER PHARMA LTD. (IL) | 2025-06-12 | — | — | US | claimed |
| EP-4565280-A1 | GRANULAR COMPOSITIONS COMPRISING A PEPTIDE AND USES THEREOF | Tarsier Pharma Ltd. (IL) | 2025-06-11 | — | — | EP | claimed |
| CN-119925587-A | Bionic personalized in-situ tumor vaccine and preparation and use methods thereof | 厦门大学 | 2025-05-06 | — | — | CN | claimed |
| CN-117398472-B | Based on Fe3O4Preparation method and application of active oxygen response type probe | 中国科学院精密测量科学与技术创新研究院 | 2025-04-08 | — | — | CN | claimed |
| WO-2025027607-A1 | PATIENT SELECTION FOR OCULAR TREATMENT | TARSIER PHARMA LTD. (IL) | 2025-02-06 | — | — | WO | claimed |
| US-20250025561-A1 | LIQUID COMPOSITIONS COMPRISING A PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE | TARSIER PHARMA LTD. (IL) | 2025-01-23 | — | — | US | claimed |
| US-12171858-B2 | Peptide for treating sepsis derived from Rv2626c protein of Mycobacterium tuberculosis | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2024-12-24 | — | — | US | claimed |
| WO-1990005536-A1 | PRODUCTS AND PROCESS FOR INCREASING THE GROWTH RATE AND/OR UTILIZATION OF FODDER OR FOODSTUFFS AND/OR RESISTANCE IN ANIMALS AND HUMANS | TEICHMANN REINHARD (DE) | 1990-05-31 | — | — | WO | claimed |
| EP-0168830-B1 | IMMUNOGLOBULIN PREPARATION IN COMBINATION WITH ANOTHER PHARMACOLOGICALLY ACTIVE PREPARATION FOR USE IN THE TREATMENT OF DISEASES | Biotest Pharma GmbH (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-0338453-A2 | A method of sensitization of small animals to the infection of human retroviruses | CO PHARMA CORPORATION S.R.L. (IT) | 1989-10-25 | — | — | EP | claimed |
| US-4734279-A | Combination of immunoglobulins with therapeutic agents | BIOTEST PHARMA GMBH (DE) | 1988-03-29 | — | — | US | claimed |
| US-4732155-A | Implantable chemoattractant system | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1988-03-22 | — | — | US | claimed |
| EP-0258672-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-09 | — | — | EP | claimed |
| EP-0225648-A2 | Compositions of matter having highly potentiated antigenic activity | YEDA RESEARCH AND DEVELOPMENT COMPANY, LTD. (IL) | 1987-06-16 | — | — | EP | claimed |
| EP-0210412-A2 | Anchoring membrane ingredient conjugate, and its use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-02-04 | — | — | EP | claimed |
| EP-0168830-A2 | Immunoglobulin preparation in combination with another pharmacologically active preparation for use in the treatment of diseases | Biotest Pharma GmbH (DE) | 1986-01-22 | — | — | EP | claimed |
| US-3997516-A | AMINO ACID OR PEPTIDE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-12-14 | — | — | US | claimed |